Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

To understand functional consequences of genetic and transcriptional aberrations in prostate cancer, the proteomic changes during disease formation and progression need to be revealed. Here we report high-throughput mass spectrometry on clinical tissue samples of benign prostatic hyperplasia (BPH),...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Latonen, Leena, Afyounian, Ebrahim, Jylhä, Antti, Nättinen, Janika, Aapola, Ulla, Annala, Matti, Kivinummi, Kati K., Tammela, Teuvo T. L., Beuerman, Roger W., Uusitalo, Hannu, Nykter, Matti, Visakorpi, Tapio
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5862881/
https://ncbi.nlm.nih.gov/pubmed/29563510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-03573-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars